drugset / Trial / NCT00487825
Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study was intended to evaluate the safety and efficacy of intravenous (IV) ACZ885 and oral methotrexate (MTX) therapy in patients with early rheumatoid arthritis (RA)
Timeline
- Start
- 2007-03
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Canakinumab | Monoclonal antibody | 600 mg | Intravenous |
| Background | Methotrexate | Small molecule | 7.5 mg | Oral |
| Background | Methotrexate | Small molecule | 15 mg | Oral |